🚀 VC round data is live in beta, check it out!
Pila Pharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pila Pharma and similar public comparables like TME Pharma, Spago Nanomedical, Bolt Biotherapeutics, Addex Therapeutics and more.
Pila Pharma Overview
About Pila Pharma
Pila Pharma AB is a clinical stage pharmaceutical company. It is developing a TRPV1 antagonist, XEN-D0501, as a novel type of oral anti-diabetic agent.
Founded
2014
HQ
Employees
3
Website
Sectors
Financials (FY)
EV
$8M
Pila Pharma Financials
Pila Pharma reported last fiscal year revenue of $123K and negative EBITDA of ($2M).
In the same fiscal year, Pila Pharma generated ($2M) in EBITDA losses and had net loss of ($2M).
Revenue (LTM)
Pila Pharma P&L
In the most recent fiscal year, Pila Pharma reported revenue of $123K and EBITDA of ($2M).
Pila Pharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $123K | XXX | XXX | XXX |
| EBITDA | — | XXX | ($2M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (1381%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (700%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($2M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (1496%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Pila Pharma Stock Performance
Pila Pharma has current market cap of $9M, and enterprise value of $8M.
Market Cap Evolution
Pila Pharma's stock price is $0.19.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $9M | 0.3% | XXX | XXX | XXX | $-0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPila Pharma Valuation Multiples
Pila Pharma trades at 69.1x EV/Revenue multiple, and (5.0x) EV/EBITDA.
EV / Revenue (LTM)
Pila Pharma Financial Valuation Multiples
As of April 19, 2026, Pila Pharma has market cap of $9M and EV of $8M.
Equity research analysts estimate Pila Pharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pila Pharma has a P/E ratio of (4.8x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $9M | XXX | $9M | XXX | XXX | XXX |
| EV (current) | $8M | XXX | $8M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 69.1x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (5.0x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (9.9x) | XXX | XXX | XXX |
| P/E | — | XXX | (4.8x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (8.5x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pila Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Pila Pharma Margins & Growth Rates
Pila Pharma's revenue in the last fiscal year declined by (100%).
Pila Pharma's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.
Pila Pharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (100%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (1381%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 53% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 800% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Pila Pharma Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pila Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| TME Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Spago Nanomedical | XXX | XXX | XXX | XXX | XXX | XXX |
| Bolt Biotherapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Addex Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Medicofarma Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pila Pharma M&A Activity
Pila Pharma acquired XXX companies to date.
Last acquisition by Pila Pharma was on XXXXXXXX, XXXXX. Pila Pharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Pila Pharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPila Pharma Investment Activity
Pila Pharma invested in XXX companies to date.
Pila Pharma made its latest investment on XXXXXXXX, XXXXX. Pila Pharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Pila Pharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pila Pharma
| When was Pila Pharma founded? | Pila Pharma was founded in 2014. |
| Where is Pila Pharma headquartered? | Pila Pharma is headquartered in Sweden. |
| How many employees does Pila Pharma have? | As of today, Pila Pharma has over 3 employees. |
| Is Pila Pharma publicly listed? | Yes, Pila Pharma is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Pila Pharma? | Pila Pharma trades under PILA ticker. |
| When did Pila Pharma go public? | Pila Pharma went public in 2021. |
| Who are competitors of Pila Pharma? | Pila Pharma main competitors are TME Pharma, Spago Nanomedical, Bolt Biotherapeutics, Addex Therapeutics. |
| What is the current market cap of Pila Pharma? | Pila Pharma's current market cap is $9M. |
| What is the current revenue of Pila Pharma? | Pila Pharma's last fiscal year revenue is $123K. |
| What is the current revenue growth of Pila Pharma? | Pila Pharma revenue growth (vs. last FY) is (100%). |
| What is the current EV/Revenue multiple of Pila Pharma? | Current revenue multiple of Pila Pharma is 69.1x. |
| Is Pila Pharma profitable? | No, Pila Pharma is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.